A detailed history of Kelly Financial Services LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kelly Financial Services LLC holds 344 shares of MRNA stock, worth $24,771. This represents 0.01% of its overall portfolio holdings.

Number of Shares
344
Previous 444 22.52%
Holding current value
$24,771
Previous $47,000 14.89%
% of portfolio
0.01%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $10,121 - $16,661
-100 Reduced 22.52%
344 $40,000
Q1 2024

Jul 17, 2024

BUY
$85.37 - $115.44 $8,537 - $11,544
100 Added 29.07%
444 $47,000
Q4 2023

Jul 17, 2024

SELL
$69.51 - $104.43 $6,047 - $9,085
-87 Reduced 20.19%
344 $34.2 Million
Q2 2023

Jul 17, 2024

SELL
$118.5 - $160.53 $1,540 - $2,086
-13 Reduced 2.93%
431 $52.4 Million
Q1 2023

Jul 17, 2024

BUY
$135.66 - $197.02 $36,492 - $52,998
269 Added 153.71%
444 $68.2 Million
Q4 2022

Jul 17, 2024

SELL
$118.38 - $210.04 $2,959 - $5,251
-25 Reduced 12.5%
175 $31.4 Million
Q3 2022

Jul 17, 2024

BUY
$118.07 - $194.18 $2,951 - $4,854
25 Added 14.29%
200 $23.7 Million
Q1 2022

Jul 17, 2024

SELL
$126.46 - $235.05 $1,643 - $3,055
-13 Reduced 6.91%
175 $30.1 Million
Q4 2021

Jul 17, 2024

SELL
$225.82 - $368.51 $42,228 - $68,911
-187 Reduced 49.87%
188 $47.7 Million
Q3 2021

Jul 17, 2024

SELL
$221.9 - $484.47 $19.5 Million - $42.5 Million
-87,743 Reduced 99.57%
375 $144 Million
Q2 2021

Jul 17, 2024

BUY
$129.91 - $234.98 $11.4 Million - $20.6 Million
87,742 Added 23335.64%
88,118 $375,000
Q1 2021

Jul 17, 2024

SELL
$109.18 - $185.98 $982 - $1,673
-9 Reduced 2.34%
376 $49.2 Million
Q4 2020

Jul 17, 2024

BUY
$65.74 - $169.86 $7,231 - $18,684
110 Added 40.0%
385 $40.2 Million
Q3 2020

Jul 17, 2024

SELL
$54.34 - $94.85 $7,009 - $12,235
-129 Reduced 31.93%
275 $19.5 Million
Q2 2020

Jul 17, 2024

BUY
$29.67 - $80.0 $10,503 - $28,320
354 Added 708.0%
404 $25.9 Million
Q1 2020

Jul 17, 2024

BUY
$17.78 - $31.58 $889 - $1,579
50 New
50 $1.5 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.